These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 5568230)

  • 1. Malignant hypertension: effect of therapy on renin and aldosterone.
    McAllister RG; Van Way CW; Dayani K; Anderson WJ; Temple E; Michelakis AM; Coppage WS; Oates JA
    Circ Res; 1971 May; 28(5):Suppl 2:160-74. PubMed ID: 5568230
    [No Abstract]   [Full Text] [Related]  

  • 2. Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease.
    Laragh JH; Baer L; Brunner HR; Buhler FR; Sealey JE; Vaughan ED
    Am J Med; 1972 May; 52(5):633-52. PubMed ID: 4337477
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute oliguric renal failure due to accelerated (malignant) hypertension.
    Sevitt LH; Evans DJ; Wrong OM
    Q J Med; 1971 Jan; 40(157):127-44. PubMed ID: 5090541
    [No Abstract]   [Full Text] [Related]  

  • 4. [Ambulant long-term treatment of arterial hypertension].
    Mühlberg H; Mühlberg G
    Z Gesamte Inn Med; 1965 Aug; 20(15):Suppl:90-3. PubMed ID: 4379548
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma renin activity and aldosterone secretion in hypertensive patients during high and low sodium intake and administration of diuretic.
    Weinberger MH; Dowdy AJ; Nokes GW; Luetscher JA
    J Clin Endocrinol Metab; 1968 Mar; 28(3):359-71. PubMed ID: 5642688
    [No Abstract]   [Full Text] [Related]  

  • 6. The pattern of plasma renin activity and aldosterone secretion in normal and hypertensive subjects before and after saline infusions.
    Espiner EA; Christlieb AR; Amsterdam EA; Jagger PI; Dobrzinsky SJ; Lauler DP; Hickler RB
    Am J Cardiol; 1971 Jun; 27(6):585-94. PubMed ID: 5088764
    [No Abstract]   [Full Text] [Related]  

  • 7. Antihypertensive action of propranolol. Specific antirenin responses in high and normal renin forms of essential, renal, renovascular and malignant hypertension.
    Bühler FR; Laragh JH; Vaughan ED; Brunner HR; Gavras H; Baer L
    Am J Cardiol; 1973 Sep; 32(4):511-22. PubMed ID: 4729721
    [No Abstract]   [Full Text] [Related]  

  • 8. Fourteen-year survival in a case of malignant hypertension under hypotensive drug therapy.
    Pomerantz HZ
    Can Med Assoc J; 1968 Nov; 99(21):1043-7. PubMed ID: 5721944
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of surgery and prolonged spironolactone therapy in patients with hypertension, aldosterone excess, and low plasma renin.
    Brown JJ; Davies DL; Ferriss JB; Fraser R; Haywood E; Lever AF; Robertson JI
    Br Med J; 1972 Jun; 2(5816):729-34. PubMed ID: 4338668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant hypertension in a patient with primary aldosteronism with elevated active renin concentration.
    Oka K; Hayashi K; Nakazato T; Suzawa T; Fujiwara K; Saruta T
    Intern Med; 1997 Oct; 36(10):700-4. PubMed ID: 9372330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant hypertension in a patient with Conn's syndrome.
    Baxter RH; Wang I
    Scott Med J; 1974 Jul; 19(4):161-3. PubMed ID: 4837570
    [No Abstract]   [Full Text] [Related]  

  • 12. Hypertension with aldosterone excess and low plasma-renin: preoperative distinction between patients with and without adrenocortical tumour.
    Ferriss JB; Brown JJ; Fraser R; Kay AW; Neville AM; O'Muircheartaigh IG; Robertson JI; Symington T; Lever AF
    Lancet; 1970 Nov; 2(7681):995-1000. PubMed ID: 4098088
    [No Abstract]   [Full Text] [Related]  

  • 13. [Diagnosis and therapy of arterial hypertension. Significance of the renin-angiotensin-aldosterone system in differential diagnosis and therapy].
    Nast HP; Philipp T
    Fortschr Med; 1974 Apr; 92(11):447-51. PubMed ID: 4362672
    [No Abstract]   [Full Text] [Related]  

  • 14. [Selection of antihypertensive drugs].
    Schelling JL
    Schweiz Med Wochenschr; 1973 Nov; 103(47):1686-9. PubMed ID: 4584764
    [No Abstract]   [Full Text] [Related]  

  • 15. [Considerations on ambulatory therapy in a group of hypertensive patients].
    Repetto S; Rezzonico A; Gervasini N
    Minerva Med; 1969 Jun; 60(51):2550-4. PubMed ID: 5792420
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapy of hypertensive crises].
    Haas Th; Denkl P
    Fortschr Med; 1977 Apr; 95(15):997-9. PubMed ID: 858582
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hypertension].
    Kishimoto M
    Naika; 1971 Jun; 27(6):1123-36. PubMed ID: 5092024
    [No Abstract]   [Full Text] [Related]  

  • 18. Recent developments in pathophysiologic studies of the renin-angiotensin system.
    Haber E
    N Engl J Med; 1969 Jan; 280(3):148-55. PubMed ID: 4302194
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of angiotensin converting enzyme inhibitor SQ 14,225 on the blood pressure, renin-angiotensin-aldosterone system and renal function in patients with malignant hypertension (author's transl)].
    Shionoiri H; Uneda S; Tochikubo O; Ohonishi T; Harada J; Sesoko S; Goto E; Fujishima S; Kaneko Y
    Nihon Jinzo Gakkai Shi; 1980 Jan; 22(1):13-22. PubMed ID: 6247528
    [No Abstract]   [Full Text] [Related]  

  • 20. Impaired renin responsiveness with secondary hypoaldosteronism.
    Gossain VV; Ferrara EV; Werk EE; Srivastava L; Privitera PJ; Hanenson I
    Arch Intern Med; 1973 Dec; 132(6):885-90. PubMed ID: 4757261
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.